Antifungal effect of Atorvastatin against Candida species in comparison to Fluconazole and Nystatin

Authors

  • Ava Nasr Esfahani
  • Zahra Golestannejad
  • Faezeh Khozeimeh
  • Parvin Dehghan
  • Mehrnoosh Maheronnaghsh
  • Zahra Zarei

DOI:

https://doi.org/10.15386/mpr-1209

Keywords:

oral candidiasis, fluconazole, Nystatin, atorvastatin, cancer chemotherapy

Abstract

Background and aims. Atorvastatin is a plasma cholesterol-lowering drug which applies antifungal effects by inhibiting the production of yeast cell wall ergostrol. The aim of present study was to investigate in-vitro susceptibility of candida species to atorvastatin, in comparison to nystatin and fluconazole.

Methods. Minimum inhibitory concentrations (MIC) and minimum fungicidal concentrations (MFC) were determined using serial dilution. Candida strains isolated from 35 patients receiving cancer chemotherapy in Isfahan, Seyyed-al-Shohada Hospital and analyzed by Kruskal-Wallis and Mann Whitney statistical methods.

Results. Candida isolates included 5 strains, C.albicans, C.glabrata, C.kefyr, C.stellatoidea and C.krusei. All five strains appeared to be resistant to nystatin and fluconazole but sensitive to atorvastatin with no statistically significant difference. The MFC of atorvastatin was significantly lower in comparison to both nystatin and fluconazole for all five strains (p value<0.05). There was no significant difference between the MFCs of 5 strains for fluconazole and atorvastatin. However, MFC of nystatin differed significantly for C. albicans and C. kefyr (p=0.007).

Conclusion. The results showed that all strains were sensitive to atorvastatin and resistant to nystatin and fluconazole. Atorvastatin MIC for C.albicans, C.krusei and C.stellatoidea was equivalent to its serum level used to treat hyperlipidemia and was above such level for both C.glabrata and C.kefyr.

Author Biographies

Zahra Golestannejad, Dental Research Center, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran

Department of Oral Medicine

Faezeh Khozeimeh, Dental Research Center, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran

Department of Oral Medicine

Parvin Dehghan, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Department of Mycology and Parasitology

Mehrnoosh Maheronnaghsh, School of Medicine, Ahvaz University of Medical Sciences, Iran

Department of Mycology and Parasitology

Zahra Zarei, Dental Research Center, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran

Department of Orthodontics

Downloads

Published

2019-10-23

How to Cite

1.
Nasr Esfahani A, Golestannejad Z, Khozeimeh F, Dehghan P, Maheronnaghsh M, Zarei Z. Antifungal effect of Atorvastatin against Candida species in comparison to Fluconazole and Nystatin. Med Pharm Rep [Internet]. 2019 Oct. 23 [cited 2025 Oct. 28];92(4):368-73. Available from: https://medpharmareports.com/index.php/mpr/article/view/1209

Issue

Vol. 92 No. 4 (2019)

Section

Original Research

License

The authors are required to transfer the copyright of the published paper to the journal. This is done by agreeing to sign the Copyright Assignment Form. Whenever the case, authors are also required to send permissions to reproduce material (such as illustrations) from the copyright holder.

 Creative Commons License
The papers published in the journal are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.